TNF and rheumatoid arthritis: Anti-TNFα agents have been approved for the treatment of various inflammatory diseases, and have proven effective in RA, psoriatic arthritis (PsA), AS; they represent the most used biologic drugs since 2000 and are usually well tolerated.